CDTVSNBIX• 28 Days (Normalized)
CDT vs NBIX (CDT Equity Inc. vs Neurocrine Biosciences Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CDT Performance $0.72
-88.51%
CDT Equity Inc.
Normalized Baseline0.00%
NBIX Performance $142.44
-8.82%
Neurocrine Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin NBIX LEADS
-79.69 pts
NBIX outperforming by 79.69 percentage points
CDTNBIX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CDT NBIX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | CDT Price | CDT Gain (%) | NBIX Price | NBIX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $0.72 | -88.51% | $142.44 | -8.82% | -79.69% |
| Oct 08, 2026 | $0.80 | -87.20% | $141.25 | -9.58% | -77.62% |
| Oct 07, 2026 | $0.84 | -86.62% | $143.47 | -8.16% | -78.46% |
| Oct 06, 2026 | $0.93 | -85.12% | $145.51 | -6.86% | -78.26% |
| Oct 05, 2026 | $0.92 | -85.32% | $144.21 | -7.69% | -77.63% |
| Oct 02, 2026 | $0.99 | -84.16% | $143.18 | -8.35% | -75.81% |
| Oct 01, 2026 | $1.25 | -80.00% | $- | - | |
| Sep 30, 2026 | $1.36 | -78.24% | $- | - | |
| Sep 29, 2026 | $1.45 | -76.80% | $- | - | |
| Sep 28, 2026 | $1.90 | -69.60% | $- | - | |
| Sep 25, 2026 | $2.00 | -68.00% | $138.40 | -11.41% | -56.59% |
| Sep 24, 2026 | $3.03 | -51.60% | $138.94 | -11.06% | -40.54% |
| Sep 23, 2026 | $3.38 | -46.00% | $139.49 | -10.71% | -35.29% |
| Sep 22, 2026 | $3.55 | -43.20% | $142.25 | -8.94% | -34.26% |
| Sep 21, 2026 | $3.85 | -38.40% | $143.96 | -7.85% | -30.55% |
Page 1 of 2